Brain-Targeted pills soothe stubborn heartburn in new study
NCT ID NCT06945237
First seen Nov 18, 2025 · Last updated May 15, 2026 · Updated 32 times
Summary
This study tested whether gut-brain neuromodulators (Flupentixol-Melitracen) can improve symptoms in people with gastroesophageal reflux disease (GERD) who still have issues despite standard acid-reducing drugs. 164 adults with GERD took part. The goal was to see if these drugs can safely reduce heartburn and other symptoms, offering a new option for those not fully helped by current treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROESOPHAGEAL REFLUX DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Jiaotong university，renji hospital
Shanghai, Shanghai Municipality, China
Conditions
Explore the condition pages connected to this study.